Evidence map›Paper›PMID 30530648›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Virus-inclusive single-cell RNA sequencing reveals the molecular signature of progression to severe dengue.

Fabio Zanini, Makeda L Robinson, Derek Croote, Malaya Kumar Sahoo, Ana Maria Sanz, Eliana Ortiz-Lasso, Ludwig Luis Albornoz, Fernando Rosso, Jose G Montoya, Leslie Goo and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 1 pooled it
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 1 synthesis or guideline pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Dengue virus infection.Nature reviews. Disease primers · 2026
    Review
  4. Article
  5. Article
  6. Biographical Feature: Benjamin A. Pinsky, MD, PhD.Journal of clinical microbiology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Integrating metagenomics and metatranscriptomics intoThe Journal of general virology · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Dengue and severe dengue.Clinical microbiology reviews · 2025
    Review
  16. Article
  17. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  18. Article
  19. Article
  20. Transcriptomics in the Study of Antiviral Innate Immunity.Methods in molecular biology (Clifton, N.J.) · 2025
    Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Fabio ZaniniDepartment of Bioengineering, Stanford University, Stanford, CA 94305.
Makeda L RobinsonDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305.
Derek CrooteDepartment of Bioengineering, Stanford University, Stanford, CA 94305.
Malaya Kumar SahooDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94304.
Ana Maria SanzClinical Research Center, Fundación Valle del Lili, Cali 760026, Colombia.
Eliana Ortiz-LassoPathology and Laboratory Department, Fundación Valle del Lili, Cali 760026, Colombia.
Ludwig Luis AlbornozPathology and Laboratory Department, Fundación Valle del Lili, Cali 760026, Colombia.
Fernando RossoClinical Research Center, Fundación Valle del Lili, Cali 760026, Colombia.
Jose G MontoyaDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305.
Leslie GooChan Zuckerberg Biohub, San Francisco, CA 94158.
Benjamin A PinskyDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305.ORCID 0000-0001-8751-4810
Stephen R QuakeDepartment of Bioengineering, Stanford University, Stanford, CA 94305; quake@stanford.edu seinav@stanford.edu.
Shirit EinavDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305; quake@stanford.edu seinav@stanford.edu.
Stanford University · USFundación Valle del Lili · COChan Zuckerberg Initiative (United States) · US

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
NIAID NIH HHS U19 AI057229
6 · The paper itself

Abstract

Dengue virus (DENV) infection can result in severe complications. However, the understanding of the molecular correlates of severity is limited, partly due to difficulties in defining the peripheral blood mononuclear cells (PBMCs) that contain DENV RNA in vivo. Accordingly, there are currently no biomarkers predictive of progression to severe dengue (SD). Bulk transcriptomics data are difficult to interpret because blood consists of multiple cell types that may react differently to infection. Here, we applied virus-inclusive single-cell RNA-seq approach (viscRNA-Seq) to profile transcriptomes of thousands of single PBMCs derived early in the course of disease from six dengue patients and four healthy controls and to characterize distinct leukocyte subtypes that harbor viral RNA (vRNA). Multiple IFN response genes, particularly MX2 in naive B cells and CD163 in CD14

Indexed as

AdultBiomarkersB-LymphocytesDengueDengue VirusDisease ProgressionFemaleHumansLeukocytes, MononuclearMaleMonocytesPlasma CellsRNA, ViralRNA VirusesSequence Analysis, RNASevere DengueBiomarkersRNA, Viralbiomarkersdenguesingle celltranscriptomicsvirus–host interactions

Identifiers

PMID30530648
PMCPMC6310786
OpenAlexW2905194441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.